Olema Pharmaceuticals, Inc. (OLMA) NASDAQ
10.96
-1.75(-13.77%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
10.96
-1.75(-13.77%)
Currency In USD
| Market Cap | 2.18B |
| Enterprise Value | 2.13B |
| P/E Ratio | -6.09 |
| PEG Ratio | -4.8 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.34 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.58 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.35 |
| Return On Equity | -0.46 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -178.21M |
| Net Income | -162.45M |
| Diluted EPS | -1.87 |
| Total Cash | 505.35M |
| Total Cash/Share | 4.92 |
| Total Debt | 956,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.88 |
| Book Value Per Share | 4.67 |
| 52-Week Change | 150.23 |
| 52-Week High | 36.26 |
| 52-Week Low | 3.89 |
| Moving Average 50 Days | 14.67 |
| Moving Average 200 Days | 16.77 |
| Average Volume | 1.48M |
| Shares Outstanding | 87.35M |
| % Held by Institutions | 116.62 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |